<?xml version="1.0" encoding="UTF-8"?>
<table-wrap-group id="t1-idmm-26-e5" position="float">
 <table-wrap id="d35e813" position="anchor">
  <label>TABLE 1</label>
  <caption>
   <p>Oseltamivir and zanamivir treatment of influenza</p>
  </caption>
  <table frame="hsides" rules="groups">
   <tbody>
    <tr>
     <td colspan="4" valign="top" align="left" rowspan="1">Updated from: The use of antiviral drugs for influenza: A foundation document for practitioners (
      <xref rid="b6-idmm-26-e5" ref-type="bibr">6</xref>)
     </td>
    </tr>
    <tr>
     <td valign="top" align="left" rowspan="1" colspan="1">
      <bold>Medication</bold>
     </td>
     <td valign="top" align="left" rowspan="1" colspan="1"/>
     <td valign="top" align="center" rowspan="1" colspan="1">
      <bold>Treatment (5 days)</bold>
     </td>
     <td valign="top" align="center" rowspan="1" colspan="1">
      <bold>Chemoprophylaxis (10 days)</bold>
     </td>
    </tr>
    <tr>
     <td colspan="4" valign="top" align="center" rowspan="1">
      <hr/>
     </td>
    </tr>
    <tr>
     <td valign="top" align="left" rowspan="1" colspan="1">
      <bold>Oseltamivir
       <sup>
        <xref ref-type="table-fn" rid="tfn2-idmm-26-e5">1</xref>
       </sup>
      </bold>
     </td>
     <td valign="top" align="left" rowspan="1" colspan="1"/>
     <td valign="top" align="center" rowspan="1" colspan="1"/>
     <td valign="top" align="center" rowspan="1" colspan="1"/>
    </tr>
    <tr>
     <td colspan="4" valign="top" align="center" rowspan="1">
      <hr/>
     </td>
    </tr>
    <tr>
     <td colspan="4" valign="top" align="center" rowspan="1">
      <bold>Adults</bold>
     </td>
    </tr>
    <tr>
     <td colspan="4" valign="top" align="center" rowspan="1">
      <hr/>
     </td>
    </tr>
    <tr>
     <td valign="top" align="left" rowspan="1" colspan="1"/>
     <td valign="top" align="left" rowspan="1" colspan="1">75 mg twice daily</td>
     <td valign="top" align="center" rowspan="1" colspan="1">75 mg once daily
      <break/>
      <bold>Children ≥12 months</bold>
     </td>
     <td valign="top" align="center" rowspan="1" colspan="1"/>
    </tr>
    <tr>
     <td colspan="4" valign="top" align="center" rowspan="1">
      <hr/>
     </td>
    </tr>
    <tr>
     <td valign="top" align="left" rowspan="1" colspan="1">Body weight (kg)</td>
     <td valign="top" align="left" rowspan="1" colspan="1">Body weight (lbs)</td>
     <td valign="top" align="center" rowspan="1" colspan="1"/>
     <td valign="top" align="center" rowspan="1" colspan="1"/>
    </tr>
    <tr>
     <td valign="top" align="left" rowspan="1" colspan="1">≤15 kg</td>
     <td valign="top" align="left" rowspan="1" colspan="1">≤33 lbs</td>
     <td valign="top" align="center" rowspan="1" colspan="1">30 mg twice daily</td>
     <td valign="top" align="center" rowspan="1" colspan="1">0 mg once daily</td>
    </tr>
    <tr>
     <td valign="top" align="left" rowspan="1" colspan="1">&gt;15 kg to 23 kg</td>
     <td valign="top" align="left" rowspan="1" colspan="1">&gt;33 lbs to 51 lbs</td>
     <td valign="top" align="center" rowspan="1" colspan="1">45 mg twice daily</td>
     <td valign="top" align="center" rowspan="1" colspan="1">45 mg once daily</td>
    </tr>
    <tr>
     <td valign="top" align="left" rowspan="1" colspan="1">&gt;23 kg to 40 kg</td>
     <td valign="top" align="left" rowspan="1" colspan="1">&gt;51 lbs to 88 lbs</td>
     <td valign="top" align="center" rowspan="1" colspan="1">60 mg twice daily</td>
     <td valign="top" align="center" rowspan="1" colspan="1">60 mg once daily</td>
    </tr>
    <tr>
     <td valign="top" align="left" rowspan="1" colspan="1">&gt;40 kg</td>
     <td valign="top" align="left" rowspan="1" colspan="1">&gt;88 lbs</td>
     <td valign="top" align="center" rowspan="1" colspan="1">75 mg twice daily</td>
     <td valign="top" align="center" rowspan="1" colspan="1">75 mg once daily</td>
    </tr>
    <tr>
     <td valign="top" align="left" rowspan="1" colspan="1"/>
     <td valign="top" align="left" rowspan="1" colspan="1"/>
     <td valign="top" align="center" rowspan="1" colspan="1">
      <bold>Children 3 months to &lt;12 months</bold>
      <bold>
       <sup>
        <xref ref-type="table-fn" rid="tfn3-idmm-26-e5">2</xref>
        <xref ref-type="table-fn" rid="tfn1-idmm-26-e5">*</xref>
       </sup>
      </bold>
     </td>
     <td valign="top" align="center" rowspan="1" colspan="1"/>
    </tr>
    <tr>
     <td colspan="4" valign="top" align="center" rowspan="1">
      <hr/>
     </td>
    </tr>
    <tr>
     <td valign="top" align="left" rowspan="1" colspan="1"/>
     <td valign="top" align="left" rowspan="1" colspan="1"/>
     <td valign="top" align="center" rowspan="1" colspan="1">3 mg/kg/dose twice daily
      <break/>
      <bold>Children &lt;3 months
       <sup>
        <xref ref-type="table-fn" rid="tfn4-idmm-26-e5">3</xref>
        <xref ref-type="table-fn" rid="tfn1-idmm-26-e5">*</xref>
       </sup>
      </bold>
     </td>
     <td valign="top" align="center" rowspan="1" colspan="1">3 mg/kg/dose once per day</td>
    </tr>
    <tr>
     <td valign="top" align="left" rowspan="1" colspan="1"/>
     <td valign="top" align="left" rowspan="1" colspan="1"/>
     <td valign="top" align="center" rowspan="1" colspan="1">3 mg/kg/dose twice daily</td>
     <td valign="top" align="center" rowspan="1" colspan="1">Not recommended unless situation judged critical due to limited data on use in this age group</td>
    </tr>
   </tbody>
  </table>
  <table-wrap-foot>
   <fn id="tfn1-idmm-26-e5">
    <label>*</label>
    <p>Please note that antivirals are not authorized for the routine treatment of seasonal influenza illness in infants &lt;1 year of age. Such use may be considered on a case-by-case basis.</p>
   </fn>
  </table-wrap-foot>
 </table-wrap>
 <table-wrap id="d35e969" position="anchor">
  <table frame="below" rules="groups">
   <tbody>
    <tr>
     <td valign="top" align="left" rowspan="1" colspan="1">
      <bold>Zanamivir
       <sup>
        <xref ref-type="table-fn" rid="tfn5-idmm-26-e5">4</xref>
       </sup>
      </bold>
     </td>
     <td valign="top" align="center" rowspan="1" colspan="1"/>
     <td valign="top" align="center" rowspan="1" colspan="1"/>
     <td valign="top" align="center" rowspan="1" colspan="1"/>
    </tr>
    <tr>
     <td colspan="4" valign="top" align="center" rowspan="1">
      <hr/>
     </td>
    </tr>
    <tr>
     <td colspan="4" valign="top" align="center" rowspan="1">
      <bold>Adults</bold>
     </td>
    </tr>
    <tr>
     <td colspan="4" valign="top" align="center" rowspan="1">
      <hr/>
     </td>
    </tr>
    <tr>
     <td valign="top" align="center" rowspan="1" colspan="1"/>
     <td valign="top" align="center" rowspan="1" colspan="1">10 mg (two 5 mg inhalations) twice daily
      <break/>
      <bold>Children (≥7 years for treatment and chemoprophylaxis)</bold>
     </td>
     <td valign="top" align="center" rowspan="1" colspan="1">10 mg (two 5 mg inhalations) once daily</td>
    </tr>
    <tr>
     <td colspan="4" valign="top" align="center" rowspan="1">
      <hr/>
     </td>
    </tr>
    <tr>
     <td valign="top" align="center" rowspan="1" colspan="1"/>
     <td valign="top" align="center" rowspan="1" colspan="1">10 mg (two 5 mg inhalations) twice daily</td>
     <td valign="top" align="center" rowspan="1" colspan="1">10 mg (two 5 mg inhalations) once daily</td>
    </tr>
   </tbody>
  </table>
  <table-wrap-foot>
   <fn id="tfn2-idmm-26-e5">
    <label>1.</label>
    <p>Oseltamivir is administered orally without regard to meals, although administration with meals may improve gastrointestinal tolerability. Oseltamivir is available in 30 mg, 45 mg, and 75 mg capsules, and as a powder for oral suspension that is reconstituted to provide a final concentration of either 6 mg/mL or 12 mg/mL. If the commercially manufactured oral suspension is not available, the capsules may be opened and the contents mixed with a sweetened liquid to mask the bitter taste or a suspension can be compounded by retail pharmacies (final concentration 15 mg/mL).</p>
    <p>When dispensing commercially manufactured Oseltamivir (TAMIFLU) Powder for Oral Suspension (6 mg/mL or 12 mg/mL), pharmacists should ensure the units of measure on the prescription instructions match the dosing device.</p>
   </fn>
   <fn id="tfn3-idmm-26-e5">
    <label>2.</label>
    <p>The above dosage provides oseltamivir exposure in children similar to that achieved by the approved dose of 75 mg orally twice daily for adults (
     <xref rid="b13-idmm-26-e5" ref-type="bibr">13</xref>–
     <xref rid="b15-idmm-26-e5" ref-type="bibr">15</xref>). The American Academy of Pediatrics recommended an oseltamivir treatment dose of 3.5 mg/kg orally twice daily for infants aged 9–11 months for the 2013–14 season. However, it is unknown whether this higher dose will improve efficacy (
     <xref rid="b14-idmm-26-e5" ref-type="bibr">14</xref>)
    </p>
    <p>Weight-based dosing is preferred. However, if weight is not known, dosing by age for treatment of influenza (give two doses per day) or prophylaxis (give one dose per day) in full-term infants &lt;1 year of age may be necessary: 0–3 months = 12 mg per dose for treatment (not for prophylaxis); 3–5 months = 20 mg per dose; 6–11 months = 25 mg per dose.</p>
   </fn>
   <fn id="tfn4-idmm-26-e5">
    <label>3.</label>
    <p>It is strongly suggested that an infectious disease physician or clinical pharmacist be consulted in the case of premature infants for whom treatment with oseltamivir is being considered. The current weight-based dosing recommendations are not appropriate for premature infants as they might have slower clearance of oral oseltamivir because of immature renal function. The following dosing is recommendations from the CDC and the AAP [14] and is based on data from the National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group using the infants’ postmenstrual age (gestational age + chronological age): 1.0 mg/kg/dose, orally, twice daily, for those &lt;38 weeks postmenstrual age; 1.5 mg/kg/dose, orally, twice daily, for those 38 through 40 weeks postmenstrual age; 3.0 mg/kg/dose, orally, twice daily, for those &gt;40 weeks postmenstrual age.</p>
   </fn>
   <fn id="tfn5-idmm-26-e5">
    <label>4.</label>
    <p>Zanamivir is administered by inhalation using a proprietary “Diskhaler” device distributed together with the medication. Zanamivir is a dry powder, not an aerosol, and should not be administered using nebulizers, ventilators, or other devices typically used for administering medications in aerosolized solutions. Zanamivir is not recommended for persons with chronic respiratory diseases such as asthma or chronic obstructive pulmonary disease that increase the risk of bronchospasm.</p>
   </fn>
  </table-wrap-foot>
 </table-wrap>
</table-wrap-group>
